Related references
Note: Only part of the references are listed.Novel Thrombolytics for Acute Ischemic Stroke: Challenges and Opportunities
Nicola Logallo et al.
CNS DRUGS (2016)
Desmoteplase After Ischemic Stroke in Patients With Occlusion or High-Grade Stenosis in Major Cerebral Arteries
Perttu J. Lindsberg et al.
STROKE (2016)
Defining Core and Penumbra in Ischemic Stroke: A Voxel- and Volume-Based Analysis of Whole Brain CT Perfusion
Yannan Yu et al.
SCIENTIFIC REPORTS (2016)
The velocity of collateral filling predicts recanalization in acute ischemic stroke after intravenous thrombolysis
Sheng Zhang et al.
SCIENTIFIC REPORTS (2016)
Desmoteplase for late treatment of stroke: still in the dark
Michael D. Hill et al.
LANCET NEUROLOGY (2015)
Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial
Gregory W. Albers et al.
LANCET NEUROLOGY (2015)
Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke
Etsuro Mori et al.
STROKE (2015)
2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2015)
Comparison of Therapeutic Effect of Recombinant Tissue Plasminogen Activator by Treatment Time after Onset of Acute Ischemic Stroke
Hai-rong Wang et al.
SCIENTIFIC REPORTS (2015)
Tissue Plasminogen Activator for preclinical stroke research: Neither rat nor human dose mimics clinical recanalization in a carotid occlusion model
Amelia J. Tomkins et al.
SCIENTIFIC REPORTS (2015)
Progress in Intravenous Thrombolytic Therapy for Acute Stroke
Randolph S. Marshall
JAMA NEUROLOGY (2015)
t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes
Be'eri Niego et al.
BLOOD (2012)
Desmoteplase: discovery, insights and opportunities for ischaemic stroke
Robert L. Medcalf
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pretreatment diffusion-and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis
Mark W. Parsons et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
Werner Hacke et al.
LANCET NEUROLOGY (2009)
Optimal Tmax Threshold for Predicting Penumbral Tissue in Acute Stroke
Jean-Marc Olivot et al.
STROKE (2009)
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial
Stephen M. Davis et al.
LANCET NEUROLOGY (2008)
The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion
Maarten G. Lansberg et al.
STROKE (2008)
The impact of recanalization on ischemic stroke outcome - A meta-analysis
Joung-Ho Rha et al.
STROKE (2007)
Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study
Gregory W. Albers et al.
ANNALS OF NEUROLOGY (2006)
MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset:: a cohort study
Martin Koehrmann et al.
LANCET NEUROLOGY (2006)
Dose escalation of desmoteplase for acute ischemic stroke (DEDAS) - Evidence of safety and efficacy 3 to 9 hours after stroke onset
AJ Furlan et al.
STROKE (2006)
Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury
C Reddrop et al.
STROKE (2005)
Refining the perfusion-diffusion mismatch hypothesis
KS Butcher et al.
STROKE (2005)
The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase
W Hacke et al.
STROKE (2005)
Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes
CA Molina et al.
STROKE (2004)
Share Paper
